Latest filing published 27 Mar 2026 for MEDIFAST INC, €7,665. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James P. Maloney (finance chief) discloses dealings in Medifast Inc to SEC (Form 4). Over a trading history stretching from 20 July 2021 to 13 March 2026, the count stands at 11 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 27 March 2026 came the latest disclosure, a share grant for €7,665 in Medifast Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations